Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

India flag India · Delayed Price · Currency is INR
68.82
+3.26 (4.97%)
At close: Jan 23, 2026
40.28%
Market Cap1.93B
Revenue (ttm)4.28B
Net Income (ttm)35.83M
Shares Out28.05M
EPS (ttm)1.25
PE Ratio54.87
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,027
Average Volume10,530
Open65.27
Previous Close65.56
Day's Range65.27 - 68.83
52-Week Range31.30 - 100.00
Beta0.52
RSI51.09
Earnings DateFeb 10, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 132
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524412
Full Company Profile

Financial Performance

In 2024, BOM:524412's revenue was 4.74 billion, an increase of 17.73% compared to the previous year's 4.03 billion. Earnings were 40.24 million, a decrease of -14.09%.

Financial Statements